Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Mirum Pharmaceuticals (MIRM) Debt Ratio (2020 - 2023)

Mirum Pharmaceuticals has reported Debt Ratio over the past 4 years, most recently at 0.0 for Q1 2023.

  • Quarterly results put Debt Ratio at 0.0 for Q1 2023, down 54.46% from a year ago — trailing twelve months through Mar 2023 was 0.0 (down 54.46% YoY), and the annual figure for FY2022 was 0.0, down 54.41%.
  • Debt Ratio for Q1 2023 was 0.0 at Mirum Pharmaceuticals, up from 0.0 in the prior quarter.
  • Over the last five years, Debt Ratio for MIRM hit a ceiling of 0.01 in Q2 2021 and a floor of 0.0 in Q4 2022.
  • Median Debt Ratio over the past 4 years was 0.01 (2020), compared with a mean of 0.01.
  • Biggest five-year swings in Debt Ratio: surged 71.48% in 2022 and later plummeted 54.46% in 2023.
  • Mirum Pharmaceuticals' Debt Ratio stood at 0.01 in 2020, then rose by 29.09% to 0.01 in 2021, then tumbled by 54.41% to 0.0 in 2022, then increased by 5.81% to 0.0 in 2023.
  • The last three reported values for Debt Ratio were 0.0 (Q1 2023), 0.0 (Q4 2022), and 0.0 (Q3 2022) per Business Quant data.